INSIGHTS & NEWS
A company called Life Biosciences has just dosed the first human patient in a trial designed to reverse damage to the optic nerve, not slow it, reverse it.
September 17, 2026
Read More
A company called Life Biosciences has just dosed the first human patient in a trial designed to reverse damage to the optic nerve, not slow it, reverse it.
Read More
